Sensei Biotherapeutics In... (SNSE)
NASDAQ: SNSE
· Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT
Sensei Biotherapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.82M | -29.03M | -30.16M | -29.8M | -29.67M | -31.92M | -34.1M | -38.92M | -45.21M | -46.36M | -48.59M | -45.72M | -41.99M | -41.23M | -36.79M | -32.56M | -28.24M | -23.38M |
Depreciation & Amortization | 734K | 697K | 800K | 604K | 604K | 936K | 1.16M | 1.37M | 1.38M | 1.37M | 1.35M | 1.32M | 1.12M | 921K | 685K | 426K | 354K | 284K |
Stock-Based Compensation | 1.85M | 2.38M | 3.13M | 3.84M | 4.16M | 4.46M | 4.45M | 4.75M | 5.19M | 5.51M | 5.81M | 5.24M | 5.5M | 5.82M | 5.66M | 5.18M | 4.23M | 2.65M |
Other Working Capital | 1.92M | 33K | 268K | 399K | -759K | -296K | -2M | -3.74M | -1.94M | -3.33M | -3.21M | -737K | -1.2M | 597K | 1.54M | -357K | -959K | -1.68M |
Other Non-Cash Items | -1.62M | 986K | 2.49M | 1.54M | 2.48M | 2.37M | 797K | 988K | 917K | 986K | 1.4M | 1.19M | 947K | 527K | 57K | 10K | 11K | 553K |
Deferred Income Tax | n/a | n/a | n/a | 356K | 142K | n/a | n/a | -356K | -142K | n/a | n/a | 199K | -154K | 19K | 19K | -180K | 173K | n/a |
Change in Working Capital | 1.59M | 818K | 250K | -400K | -763K | -2.56M | -4.33M | -3.27M | 291K | -1.52M | 1.01M | 446K | -1.51M | 3.69M | 117K | 2.05M | -1.82M | -2.12M |
Operating Cash Flow | -24.27M | -24.15M | -24.67M | -25.04M | -24.23M | -27.9M | -32.02M | -35.43M | -37.58M | -40.01M | -39.03M | -37.32M | -36.09M | -30.24M | -30.26M | -25.07M | -25.29M | -22.01M |
Capital Expenditures | -16K | -109K | -146K | -146K | -146K | -66K | -180K | -251K | -501K | -524K | -392K | -856K | -994K | -1.56M | -2.03M | -1.81M | -2.25M | -1.64M |
Cash Acquisitions | n/a | n/a | n/a | -166K | -166K | -9K | -9K | 157K | 172K | 1.75K | 1.75K | -120.88M | -120.9M | -120.89M | -120.89M | n/a | n/a | -197 |
Purchase of Investments | -35.39M | -44.69M | -44.59M | -29.44M | -29.29M | -17.56M | -21.15M | -388K | -13.45M | -48.7M | -46.87M | -74.87M | -79.79M | -191.69M | -183.67M | -173.82M | -147.15M | n/a |
Sales Maturities Of Investments | 60.87M | 68.61M | 67.18M | 63.44M | 58.69M | 59.34M | 59.58M | 46.59M | 60.09M | 89.19M | 97.12M | 115.23M | 110.99M | 62.49M | 42.26M | 26.26M | n/a | n/a |
Other Investing Acitivies | 250K | 40K | 5.81K | 171.81K | 180.12K | 199.67K | 202.87K | 107.87K | 108.32K | 102.02K | 105.23K | 120.92M | 147.49M | 330.21K | 318K | -120.57M | -147.15M | -197K |
Investing Cash Flow | 25.71M | 23.86M | 22.44M | 33.85M | 29.25M | 41.87M | 38.41M | 46.19M | 46.4M | 40.07M | 49.95M | 39.52M | 30.52M | -130.44M | -143.12M | -149.05M | -149.4M | -1.84M |
Debt Repayment | -411K | -612K | -811K | -800K | -786K | -774K | -761K | -742K | -715K | -682K | -629K | -679K | -523K | -378K | -255K | -38K | -41K | 526K |
Common Stock Repurchased | 10.00 | 10.00 | n/a | -252K | -2.6M | -10.38M | -10.38M | -10.13M | -7.79M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -369K | -180K | 24K | -20K | -20K | -10K | -76K | 8K | 8K | 14K | 342K | 397K | 397K | 360K | 109K | -2.08M | -2.08M | -2.08M |
Financial Cash Flow | -780K | -792K | -787K | -1.02M | -3.35M | -11.12M | -11.17M | -10.87M | -8.49M | -668K | -287K | -163.12K | -125 | 118.86K | 163.94K | 16.02M | 24.5M | 25.06M |
Net Cash Flow | 666K | -1.08M | -3.02M | 7.79M | 1.67M | 2.85M | -4.78M | -107K | 327K | -612K | 10.64M | 1.92M | -5.7M | -160.7M | -9.44M | 5.8M | 13.71M | 165.12M |
Free Cash Flow | -24.28M | -24.26M | -24.82M | -25.19M | -24.38M | -27.97M | -32.2M | -35.69M | -38.08M | -40.54M | -39.42M | -38.18M | -37.09M | -31.8M | -32.28M | -26.88M | -27.55M | -23.65M |